Standout Papers
Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
2012
Pax2/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney
2005
STAR: ultrafast universal RNA-seq aligner
2012 Standout
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
2008
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2015
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
2014 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Triple negative breast cancer: unmet medical needs
2010
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer
2006
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer
2014
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
2012
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
2016
Triple-Negative Breast Cancer
2010 Standout
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncogenic roles of EMT-inducing transcription factors
2014
Circular RNAs are a large class of animal RNAs with regulatory potency
2013 StandoutNature
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
2012 Standout
Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer
2011
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
2007
Epithelial–mesenchymal plasticity in carcinoma metastasis
2013
Novel Treatment Approaches for Triple-Negative Breast Cancer
2010
Detecting and characterizing circular RNAs
2014 Standout
Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)
2012
Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model
2007
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
2008
Histological and molecular types of breast cancer: is there a unifying taxonomy?
2009
MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
2011
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
2015
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Insight into the heterogeneity of breast cancer through next-generation sequencing
2011
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Improving RNA-Seq expression estimates by correcting for fragment bias
2011
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
2014
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Circular RNAs are abundant, conserved, and associated with ALU repeats
2012 Standout
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
2015
EMT: 2016
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
Gene-Expression Signatures in Breast Cancer
2009
Heterogeneity in breast cancer
2011
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
2016 Nature
Circular RNAs: diversity of form and function
2014
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
2012
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
2013
Gene Signature in Melanoma Associated With Clinical Activity
2010
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
2015 Nature
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
2013 Standout
Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4
2010
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Computational methods for transcriptome annotation and quantification using RNA-seq
2011
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
2013 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Angiopoietin-like 4: a decade of research
2011
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
RNA-seq with RNase H-based ribosomal RNA depletion specifically designed for C. elegans
2020 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
2012
Targeting claudins in cancer: diagnosis, prognosis and therapy.
2021
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
PASSion: a pattern growth algorithm-based pipeline for splice junction detection in paired-end RNA-Seq data
2012
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
2010
GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value
2008
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
Comparative analysis of RNA-Seq alignment algorithms and the RNA-Seq unified mapper (RUM)
2011
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
2014
Hypoxia‐inducible factor regulates osteoclast‐mediated bone resorption: role of angiopoietin‐like 4
2010
ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters
2011
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
2007
Works of Xiaping He being referenced
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
2011
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
2008
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
2013
A compact VEGF signature associated with distant metastases and poor outcomes
2009
EGFR associated expression profiles vary with breast tumor subtype
2007
Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity
2015
Mutation of GATA3 in human breast tumors
2004
Gene expression patterns associated with p53 status in breast cancer
2006
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
2010 Standout
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
2011
MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
2010
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
2014
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
2006
Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer
2005
TBCRC 001: EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative (basal-like) breast cancer
2008